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4-Alkyl-L-Proline Precursors of
Lincomycin, Hormaomycin, and
Pyrrolobenzodiazepines: Could a
γ-Glutamyltransferase Cleave the
C–C Bond?
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Lucie Najmanova, Stanislav Kadlcik, Jitka Novotna†, Marek Kuzma and Jiri Janata*
Institute of Microbiology – Academy of Sciences of the Czech Republic, Prague, Czech Republic
Structurally different and functionally diverse natural compounds – antitumour
agents pyrrolo[1,4]benzodiazepines, bacterial hormone hormaomycin, and lincosamide
antibiotic lincomycin – share a common building unit, 4-alkyl-L-proline derivative (APD).
APDs arise from L-tyrosine through a special biosynthetic pathway. Its generally
accepted scheme, however, did not comply with current state of knowledge. Based on
gene inactivation experiments and in vitro functional tests with recombinant enzymes,
we designed a new APD biosynthetic scheme for the model of lincomycin biosynthesis.
In the new scheme at least one characteristic in each of five final biosynthetic steps
has been changed: the order of reactions, assignment of enzymes and/or reaction
mechanisms. First, we demonstrate that LmbW methylates a different substrate than
previously assumed. Second, we propose a unique reaction mechanism for the next
step, in which a putative γ-glutamyltransferase LmbA indirectly cleaves off the oxalyl
residue by transient attachment of glutamate to LmbW product. This unprecedented
mechanism would represent the first example of the C–C bond cleavage catalyzed
by a γ-glutamyltransferase, i.e., an enzyme that appears unsuitable for such activity.
Finally, the inactivation experiments show that LmbX is an isomerase indicating that
it transforms its substrate into a compound suitable for reduction by LmbY, thereby
facilitating its subsequent complete conversion to APD 4-propyl-L-proline. Elucidation
of the APD biosynthesis has long time resisted mainly due to the apparent absence
of relevant C–C bond cleaving enzymatic activity. Our proposal aims to unblock this
situation not only for lincomycin biosynthesis, but generally for all above mentioned
groups of bioactive natural products with biotechnological potential.
Keywords: anticancer drug, antibiotics, natural product biosynthesis, secondary metabolism, 4-propyl-L-proline,
lincomycin, pyrrolobenzodiazepine, hormaomycin
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INTRODUCTION
4-Alkyl-L-proline derivatives (APDs) are specialized precursors
that are common for three groups of structurally different
secondary metabolites (Figure 1) with various but remarkable
biological activities: pyrrolo[1,4]benzodiazepines (PBDs;
Leimgruber et al., 1965; Gauze et al., 1969; Kariyone et al.,
1971; Tsunakawa et al., 1988) are sequence-selective DNA
alkylating agents with significant antitumor properties (for
review see Gerratana (2012)), ribosome binding lincomycin
(Hoeksema et al., 1964) produced by Streptomyces lincolnensis is
a clinically used lincosamide antibiotic, and hormaomycin from
Streptomyces griseoflavus (Rössner et al., 1990) is a microbial
hormone that is involved in the quorum-sensing system. Some
PBDs and lincosamides incorporate proteinogenic L-proline
instead of APD in their structures (e.g., DC-81, neothramycin or
tilivalline in PBDs and lincosamide celesticetin), however, these
compounds exhibit low biological activity. The length and/or
modification of the alkyl chain of the proline moiety affect the
efficiency (Magerlein, 1977; Gerratana, 2012). Modification of
this parameter, e.g., by mutasynthesis, appears to be an important
tool for achieving the production of more efficient derivatives
(Ulanova et al., 2010).
The APD precursors arise from L-tyrosine through a
specialized biosynthetic pathway. Based on feeding experiments
with labeled L-tyrosine and L-DOPA in the biosynthesis of
lincomycin (Brahme et al., 1984) and some PBDs (Hurley et al.,
1979), the general scheme of the APD pathway was proposed
(Figure 2): L-tyrosine is first converted to L-DOPA, which
further undergoes extradiol cleavage to a 5-alanyl-2-hydroxy-
muconate 6-semialdehyde (1). Following cyclization yields two
tautomers, a cyclic imine 2 and a cyclic α-ketoacid 3. Their
equilibrium is strongly shifted in favor of acid 3 (approximately
95:5; Saha et al., 2015). These initial steps were confirmed
through a direct biochemical proof (Neusser et al., 1998;
Novotna et al., 2004, 2013; Colabroy et al., 2008, 2014; Connor
et al., 2011; Saha et al., 2015), but the subsequent steps of
this pathway still remain only hypothetical. Generally, it is
hypothesized that cleavage of the two carbon residue from
the side chain of 3 results in carboxylic acid 4, which is
considered to be the first branch point in the biosynthesis of
secondary metabolites containing APD (Figure 2; Hurley et al.,
1979).
Comparison of relevant biosynthetic gene clusters for APD-
incorporating compounds, such as the PBDs anthramycin (Hu
et al., 2007), sibiromycin (Li et al., 2009b), tomaymycin (Li et al.,
2009a), and porothramycin (Najmanova et al., 2014); lincomycin
(Koberska et al., 2008); and hormaomycin (Höfer et al., 2011),
reveals the presence of a set of 5–6 homologous genes shared
by all mentioned clusters (Table 1) and thus assigned to the
APD biosynthetic pathway. In contrast, in the clusters for related
compounds that incorporate L-proline instead of APD, such as
the lincosamide celesticetin (Janata et al., 2015) and the PBD
tilivalline (Schneditz et al., 2014), the whole set is missing.
In lincomycin biosynthesis, the specific product of the APD
pathway, the 4-propyl-L-proline (PPL) precursor, is condensed
(Kadlcik et al., 2013; Janata et al., 2015; Zhao et al., 2015)
with the amino octose unit, which is a product of another
specialized pathway (Sasaki et al., 2012; Lin et al., 2014).
The resulting lincosamide scaffold is further modified to the
final product, lincomycin A (lincomycin, unless otherwise
specified; Figure 1; Kamenik et al., 2016). Correspondingly
with PPL incorporation, the full set of six APD putative
biosynthetic genes is present in the lincomycin biosynthetic
cluster (Table 1). Two of these genes encode the L-tyrosine
hydroxylating enzyme (LmbB2) and L-DOPA-2,3-dioxygenase
(LmbB1), catalyzing the first two steps of the PPL pathway
(Figure 2). Proteins LmbA, LmbW, LmbX and LmbY, encoded
by the remaining four genes, thus presumably catalyze all
subsequent PPL biosynthetic steps. Seven out of nine carbons
of the initial L-tyrosine molecule were demonstrated in the
PPL structure, while two are removed and one comes from
S-adenosylmethionine (Brahme et al., 1984). Accordingly, LmbX
was predicted to cleave off the two-carbon oxalyl residue from
α-ketoacid 3 and LmbW to methylate the resulting compound 4
(Li et al., 2009a,b), yielding characterized intermediate 5 (Kuo
et al., 1992). While the methylation function of LmbW was
recently documented by inactivation of the coding gene (Pang
et al., 2015), in the case of LmbX, the predicted C–C cleavage
function is contradictory: (1) LmbX belongs, based on sequence
homology, to the isomerase protein family and (2) the LmbX
homolog is missing in the hormaomycin biosynthesis (Höfer
et al., 2011), but the structure of hormaomycin does not
correspond with the lack of the C–C cleavage functionality.
Lincomycin and hormaomycin both incorporate the APD
precursor with the same length of alkyl side chain but
with different levels of saturation. Moreover, the proposed
function of LmbA (activation of cofactor for F420-dependent
reductase LmbY, where the glutamate ligase activity should
be expected) does not correspond to its sequence homology
to γ-glutamyltransferases (EC 2.3.2.2; Castellano and Merlino,
2012).
The aim of this work was to revise the APD biosynthetic
pathway on the lincomycin model based on recent literature
data and our results from gene inactivation experiments and
functional testing of individual proteins with compound 3 as a
substrate.
RESULTS
Production of Lincomycin Derivatives
and Amino Acid Precursors by S.
lincolnensis and its Deletion Mutant
Strains
Overview of Detected Compounds
Streptomyces lincolnensis ATCC 25466 (wt strain) and its mutant
strains with a relevant gene(s) deleted were cultured and
analyzed for the production of lincomycin, its derivatives and
corresponding amino acid precursors (summarized in Figure 3).
Relevant structures are shown in Figure 4. In addition to
lincomycin A (LIN A) bearing a three-carbon side chain (3C;
n-propyl) at the C-4′ position of the amino acid moiety and
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FIGURE 1 | Natural compounds containing an APD moiety with already known biosynthetic gene clusters (structures originating from APD
biosynthesis are in red).
the side product lincomycin B (LIN B), bearing a two-carbon
side chain (2C; ethyl) at the same position (Figure 4), we found
several previously undescribed lincomycin derivatives with a
modification in their amino acid moiety: DH-LIN A, DH-LIN
B, and OXO-LIN A. Moreover, we searched for compounds
corresponding to the amino acid precursors of LIN A and LIN
B, PPL, and 4-ethyl-L-proline (EPL), respectively (Figure 4); for
precursors of the newly identified lincomycin derivatives, DH-
PPL, DH-EPL, and OXO-PPL; and finally for the previously
identified intermediate (DH)2-PPL (Kuo et al., 1992). All of
these compounds are defined by their elemental composition
(Supplementary Figures S1A,B), and their abbreviations indicate
the difference compared to LIN A, LIN B, PPL, or EPL: DH
and (DH)2 represent the presence of one or two double bonds,
respectively, and OXO indicates the presence of one additional
O and two less H atoms. Further identification (comparison
with authentic standards, MS fragmentation, and NMR) is
shown in Figure 3 and evidenced in Supplementary Figures
S1C,D and Supplementary Table S1. The production profiles
provide useful clues for probing the PPL biosynthetic machinery.
Therefore, they are described in further detail below, and
their magnified versions are depicted in Supplementary Figure
S1E.
The nomenclature of isomers was based on their retention
order. For the LIN A example, a stereoisomer with the 2′S,4′R
configuration (CAS number 154-21-2) was detected as the later
eluting predominant product of wt strain and termed LIN A2
(11b). However, another earlier eluted minor stereoisomer of
LIN A, termed LIN A1 (11a), presumably having the 2′S,4′S
configuration, was detected (Figures 3A and 4).
Production Profile of 1lmbW Strain
The lmbW gene inactivation resulted in abolition of LIN A
production, and no other lincomycin derivatives with the 3C side
chain were detected. Nevertheless, the production of LIN B was
unaffected or even increased, and accordingly, only significant
accumulation of the relevant EPL precursor (10) was detected.
Production Profile of 1lmbX Strain
As the main product of the 1lmbX strain, we detected two DH-
LIN A isomers: DH-LIN A1 (13a) and DH-LIN A3 (13b). Their
structures were confirmed by NMR analysis (Supplementary
Table S1), revealing that both isomers contain a double bond,
located in the middle of the 3C side chain in a Z-configuration
(Figure 4). The two isomers differ in absolute configuration
at either C-2′ or C-4′; C-4′ being more probable because
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FIGURE 2 | Previously proposed APD biosynthetic pathway scheme. According to Li et al. (2009b), adapted for PPL biosynthesis, i.e., sibiromycin
biosynthetic proteins were substituted by lincomycin homologs. Dotted arrows indicate branch points of the pathway leading to particular APDs incorporating natural
compounds (in capitals).
it corresponds with utilization of L-tyrosine as a starting
compound. The production of other lincomycin derivatives was
low, and all the compounds were produced in two isomers
with comparable ratios or favoring the earlier eluting isomers.
Additionally, these isomers likely differ in terms of the absolute
configuration at C-4′. Furthermore, we detected precursors PPL
(7), EPL (10), DH-PPL1 (8), and OXO-PPL, corresponding
to the lincomycin derivatives produced by this strain, and we
also detected a low amount of (DH)2-PPL1 (9; Figure 4). The
structures of relevant unsaturated precursors 8 and 9 were
derived based on retro-(bio)synthetic analysis of determined
products 13a and 13b (Figure 4). When complemented with
plasmid-bearing lmbX gene under control of a constitutive
promotor, the 1lmbX strain restored the production profile of
the wt strain (data not shown).
Production Profile of 1lmbW1lmbX Strain
Similar to single lmbW gene inactivation, no lincomycin
derivatives with the 3C side chain were detected. Only LIN
B and DH-LIN B were produced, both in two isomers,
resembling the production profile of the 1lmbX strain.
The corresponding precursors, EPL and DH-EPL, were also
detected.
Production Profile of 1lmbY Strain
The production of LIN A and LIN B was not abolished. However,
the concentration of the main product LIN A2 decreased
considerably compared to the wt strain (wt: 35 ± 15 µg/ml;
1lmbY : 10 ± 5 µg/ml), as quantified based on UV detection.
Furthermore, we detected two isomers of DH-LIN A, DH-
LIN A2 (14a) and DH-LIN A4 (14b), with different retention
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TABLE 1 | Homologous proteins involved in the APD biosynthesis shared by producing strains of relevant compounds.
Previously proposed function Sequence homology to Lincomycin Hormaomycin Anthramycin Porothramycin Sibiromycin Tomaymycin
3-Hydroxylation of L-tyrosine∗ L-Tyrosine-3-hydroxylase LmbB2∗ HrmE ORF13∗ POR14 SibU TomI
Extradiol cleavage of L-DOPA∗ L-DOPA-2,3-dioxygenase LmbB1∗ HrmF∗ ORF12∗ POR13 SibV∗ TomH
Cleavage of C–C bond of 3∗∗ Isomerase LmbX — ORF15 POR16 SibS TomK
C-Methylation of 4∗∗∗ C-Methyltransferase LmbW HrmC ORF5 POR10 SibZ —
Activation of F420 cofactor∗∗ γ-Glutamyltransferase LmbA HrmG ORF6 POR11 SibY TomL
Reductions of 5 to give 7∗∗∗∗ F420-dependent
reductase
LmbY HrmD ORF14 POR15 SibT TomJ
∗Function has been proved previously (Novotna et al., 2004, 2013; Connor et al., 2011; Saha et al., 2015). ∗∗Previously proposed function not consistent with sequence
homology (in bold); novel functions proposed in this paper. ∗∗∗Previously proposed function consistent with sequence homology; novel substrate proposed in this paper.
∗∗∗∗Previously proposed function consistent with sequence homology; novel mode of action and novel intermediate proposed in this paper.
times compared to DH-LIN A1 (13a) and DH-LIN A3 (13b)
produced by the 1lmbX strain (see separation of all DH-
LIN isomers under isocratic conditions in Figure 3A). The
structure of DH-LIN A2 (14a) was elucidated by NMR
(Supplementary Table S1), revealing that the double bond is
exocyclic, attached to the C-4′ carbon (Figure 4). However,
unambiguous determination of its relative configuration on
the basis of NMR data was not possible. Apart from the
precursors of the identified lincomycin derivatives, i.e., PPL
(7), DH-PPL2 (6), and EPL (10), we observed a high
accumulation of (DH)2-PPL2 (5; Figure 4) without any relevant
lincomycin-derivative product. Structures 5 and 6 were derived
from product 14a analogously to intermediates 8 and 9
(Figure 4).
Production Profile of 1lmbA Strain
Only trace amounts of LIN A and LIN B were detected. OXO-
LIN A was found as the main product, but in a low amount.
All identified products were present in single-isomer form: LIN
A2, LIN B2, and OXO-LIN A2. Additionally, we did not detect
any lincomycin precursors. When complemented with plasmid-
bearing lmbA gene under control of a constitutive promotor, the
1lmbA strain restored the production profile of the wt strain
(data not shown).
Functional Tests with Recombinant
LmbX and LmbW Proteins
LmbX did not Cleave Oxalyl Residue of
Intermediate 3
Protein LmbX was proposed to catalyze the cleavage of the C–C
bond, resulting in the release of oxalyl residue from 3 (Li et al.,
2009b). We tested soluble LmbX protein under various reaction
conditions with 3 as a substrate (see Experimental procedures).
However, we did not detect cleavage of the oxalyl residue or any
other turnover of 3 caused by LmbX.
LmbW Methylated Intermediate 3
Recombinant protein LmbW was tested with 3 as a substrate.
However, under acidic chromatographic conditions, the starting
material 3 was detected as a mixture of 3 and apparently its
early eluting acyclic form 1, likely resulting from hydrolysis of
the enamine group of 3 (Figure 5A; evidenced by MS and UV
spectra in Supplementary Figure S2). Indeed, this sensitivity of 3
to acidic hydrolysis has been previously demonstrated (Colabroy
et al., 2008; Saha et al., 2015). In the reaction with LmbW
and S-adenosylmethionine, we identified a product (Figure 5B
and Supplementary Figure S2) with the elemental composition
C10H13NO6. The data are consistent with the product being
15, i.e., methylated 1. The assumption that the product has
its enamine group hydrolyzed is supported by the similar
polarities of 15 and 1 and the considerably lower polarity of
15 compared to 3. Additionally, both compounds 1 and 15
presented similar MS spectra patterns with a significant (15) or
even predominant (1) fragment of loss of water, corresponding
to the loss of hydroxyl present in both enol tautomers 1
and 15 (Supplementary Figure S2). We assume that 1 and
15 were detected as a consequence of the acidic conditions
used during the chromatographic analysis, and it is actually
3, which is methylated to afford 16 in an in vivo system
(Figure 5C).
A New Concept of APD Biosynthetic
Pathway
Contradictory Steps of the Previously Proposed
Biosynthetic Pathway
In addition to those mentioned in the introduction, our
experimental results revealed several further contradictions in
terms of the currently accepted theoretical scheme of APD
biosynthesis (Figure 2):
LmbX does not cleave an oxalyl residue from intermediate
3. Accordingly, deletion of lmbX gene resulted in products
with incorporated 3C unsaturated APD moiety, similar or even
identical as in hormaomycin (its producer lacks LmbX homolog).
LmbW unexpectedly methylates intermediate 3.
LmbA does not activate F420 cofactor of LmbY reductase
(Peschke et al., 1995), because the production profiles of the
1lmbY and 1lmbA strains are completely different. Moreover,
deletion of the lmbA gene resulted in the most efficient block
in PPL biosynthesis among all putative APD biosynthetic genes
tested, indicating that LmbA catalyzes a key step in the PPL
pathway.
These contradictions provided us with convincing evidence
that the originally proposed biosynthetic scheme (Figure 2)
required a revision. Moreover, it encouraged us to design a new
scheme for PPL biosynthesis (Figure 6A) that assigns functions
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FIGURE 3 | Production profiles of wt and deletion mutant strains. (A) Lincomycin derivatives and (B) Amino acid precursors. LC–MS ion extracted
chromatograms; Extraction window: 0.025 Da. Not relevant peaks (assigned with ×) do not represent [M+H]+, but a fragment of different species, or their mass
error exceeds 5 ppm compared to the theoretical elemental composition (see also Supplementary Figures S1A–E).
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FIGURE 4 | Structures of identified products and precursors found in culture broths of wt and deletion mutant strains and their biosynthetic
relations. Letters in square brackets indicate methods used for corresponding structure identification: a – elemental composition from isotopic pattern and accurate
mass (Supplementary Figures S1A,B); b – comparison of retention times with authentic standards (Supplementary Figure S1C); c – in-source CID MS fragmentation
(Supplementary Figure S1D); d – NMR analysis (Supplementary Table S1); e – retro-(bio)synthetic approach (indicated by retrosynthetic arrows starting from
completely identified products 13a, 13b, and 14a). ∗Tentative structure (absolute or relative configuration is proposed based on the knowledge of the major isomer
structure).
to all the remaining proteins whose functions have not yet been
confirmed. Specifically, we have assigned new functions to LmbA
and LmbX and a new substrate to LmbW, while the role of LmbY
remained basically the same as was originally proposed, i.e.,
reduction of double bonds of 5. The newly proposed biosynthetic
scheme is fully consistent with published data and with our
results, and its individual steps are discussed in further detail
below.
DISCUSSION
I. Methylation Catalyzed by LmbW
(Conversion of 3 to 16)
The in vitro methylation of 3 by recombinant LmbW led to
its conversion into a product 16 (observed due to an acidic
hydrolysis of enamine in its acyclic form 15). Theoretically, the
substrate specificity of LmbW can be relaxed, and therefore,
we cannot exclude the previously proposed intermediate 4
(Hurley et al., 1979) from being the main natural substrate.
However, we consider this alternative unlikely for the following
reasons: (1) The methylation of both 3 and 4 by LmbW would
require the existence of two different mechanisms of action –
the methylation of enolate in 3 versus the methylation of the
conjugated system of double bonds in 4. (2) The methylation
of 4 cannot explain the presence of the two different forms of
(DH)2-PPL (5 and 9), as documented by us in mutant strains
1lmbX and 1lmbY, because it should lead to only a single
form 5 (Figure 2). (3) Two proteins with significant sequence
homology to LmbW, MrsA (26% identity with coverage of 74%
according to blastp; Braun et al., 2010) and MppJ (26% identity,
78% coverage; Huang et al., 2009), were demonstrated to be
C-methyltransferases of compounds sharing structural features
with 3 (methylation occurs at the α-position to the carbonyl
group of pyruvate residue). (4) Intermediate 4 has never been
detected.
The production of lincomycin derivatives not only complies
with the methyltransferase function of LmbW but they also reveal
that LmbW is dispensable for the PPL/lincomycin biosynthetic
machinery. First, lmbW deletion abolished the production of
all 3C lincomycin derivatives, but not 2C derivatives (LIN B
in 1lmbW and 1lmbW1lmbX strains and DH-LIN B in the
latter one, Figure 3A), which means that all enzymes catalyzing
the following steps in PPL biosynthesis, i.e., LmbA, LmbX, and
LmbY, as well as all condensation/post-condensation proteins
(Kadlcik et al., 2013; Janata et al., 2015; Zhao et al., 2015;
Kamenik et al., 2016), exhibit a relaxed substrate specificity and
accept to a certain extent substrates with both two- and three-
carbon side chains. Second, a natural system missing the LmbW
homolog (biosynthesis of the PBD tomaymycin) analogously
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FIGURE 5 | Conversion of 3 by recombinant LmbW. (A) Starting material: LC–MS ion extracted chromatogram at m/z 210.0402 – [M-H]− of 3 and [M-H-H2O]−
of 1. (B) Product: LC–MS ion extracted chromatogram at m/z 242.0665 – [M-H]− of 15. (C) Methylation catalyzed by LmbW including equilibrium with hydrolyzed
forms of starting material and product. UV and MS spectra of substrate(s) and the product are shown in Supplementary Figure S2.
incorporates a 2C APD precursor into the final product (Li
et al., 2009a). Third, this C-methylation step can be omitted even
in strains with functional LmbW (for detailed explanation see
legend of Figure 6). Thus, 2C lincomycin derivatives, particularly
LIN B, were detected along with the 3C ones in all the tested
strains.
It is challenging to clarify the fate of the LmbW product 16
when considering expected functions of the remaining LmbX,
LmbY, and LmbA proteins. However, the results of inactivation
experiments and recently published data provide a realistic basis
for the elucidation of the final steps of PPL biosynthesis catalyzed
by LmbX and LmbY (Discussion part II). Only having explained
this part of PPL biosynthesis, we are able to deal with the
conversion of 16 (Discussion part III).
II. Reduction of Double Bonds: The Role
of LmbX and LmbY (Conversion of 9 to 7)
Protein LmbY exhibits significant homology to F420-dependent
oxidoreductases and is supposed to catalyze two reduction steps,
converting intermediate 5 to PPL (7; Kuo et al., 1992; Peschke
et al., 1995). Indeed, the major accumulated intermediate in
1lmbY mutant strain was compound with two double bonds
[(DH)2-PPL2 – presumably intermediate 5; Figures 3B and 4].
However, except this expected intermediate, two other minor
intermediates [DH-PPL2 (6) and PPL (7)] were also found in the
cultivation broth of this mutant strain. Their formation can be
explained by either partial or full reduction of 5 by an alternative,
less selective (and less efficient) reductase, which is likely encoded
outside the lincomycin biosynthetic cluster (Figure 7C). The
presence of unsaturated intermediates (DH)2-PPL1 (9) and DH-
PPL1 (8) in the 1lmbX mutant strain, indicating seeming LmbX
participation in the reduction of double bond(s), appears to
be unexpected as well, because LmbX exhibits no sequence
homology to oxidoreductases. LmbX is homologous to PhzF
protein (27% identity with coverage of 94% according to blastp),
which has been proven to be an isomerase (Blankenfeldt et al.,
2004; Parsons et al., 2004). As apparent from the production
profile of the 1lmbX mutant strain, the reduction of the
endocyclic double bond present in 9 proceeds quite readily,
and only trace amounts of this intermediate were detected.
However, the complete reduction to PPL (7) is inefficient and
results in the production of unsaturated lincomycin derivatives
(13a and 13b) from corresponding precursor 8 (Figure 3).
It indicates that LmbY is able to effectively reduce exocyclic
double bond in 5, but not the side chain double bond in 9.
An isomerase activity could solve this situation by converting
9 to its isomer 5, which represents a more suitable substrate
of LmbY. We hypothesize this role for the putative isomerase
LmbX.
LmbY presumably utilizes F420 cofactor, which is able to
transfer the hydride ion (Schauer et al., 1986). Hydride reduction
requires generally the presence of a polarized double bond,
and thus, reduction of the polarized endocyclic double bond
(imine) should occur. However, intermediate 5 contains the
second double bond in conjugation with imine. This mutual
position of double bonds enables the so-called conjugate addition
of hydride ion to the more distant exocyclic double bond,
affording intermediate 17, which is further reduced to PPL (7)
by reduction of polar endocyclic double bond (Figure 7A). In
contrast, intermediate 9 does not allow this conjugate addition
and its reduction proceeds predominantly at endocyclic double
bond (imine), affording 8 (Figure 7B). The side chain double
bond in 8 is further reduced very unwillingly (it is non-
polar) and 8 will predominate compared to 7 in the 1lmbX
strain. Therefore, the strains lacking LmbX or its homolog
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FIGURE 6 | Newly proposed scheme of the PPL biosynthetic pathway. The overall PPL biosynthetic scheme (A) was elucidated discontinuously in two parts
marked by solid-line frames. New structures and newly proposed protein functions are in red. ∗ Initial three steps see Figure 2. Biosynthesis of EPL differs only
slightly, methylation step catalyzed by LmbW is missing, compound 3 is directly cleaved by LmbA to analog of 9 containing ethyliden side chain instead of
propyliden, further steps are similar as in PPL biosynthesis, but the compounds 5, 17, and 7 are substituted by analogs with the 2C side chain. (B) The deduced
mechanism of action of γ-glutamyltransferase LmbA (corresponds to dotted frame in A). Roman numerals indicate reaction intermediates (see Discussion III).
(1lmbX strain and hormaomycin producer) predominantly
synthesize products with precursor 8 incorporated in their
structures – DH-LIN A1 (13a), DH-LIN A3 (13b) and
hormaomycin.
The rate of incorporation of individual unsaturated
precursors to final biosynthetic products (lincomycin and
its derivatives) indicates another important finding, the
substrate specificity of the condensation and post-condensation
lincomycin biosynthetic system. Apparently, this system is
able to incorporate not only saturated precursors [PPL, EPL; in
accordance with Kadlcik et al. (2013)] but also mono-unsaturated
ones containing double bond located in the side chain (6 and 8).
On the other hand, the lincomycin derivatives incorporating
APD precursor containing two double bonds have not been
observed at all even though at least 5 was accumulated by1lmbY
mutant strain. However, it is impossible to decide, whether the
endocyclic double bond itself or its combination with the side
chain double bond prevents incorporation.
III. Cleavage of Oxalate Catalyzed by
LmbA (Conversion of 16 to 9)
Compounds 16 (Figure 6A, likely the product of the methylation
of 3 catalyzed by LmbW) and 9 (probable substrate of LmbX)
constitute two distinct intermediates in the biosynthetic pathway
of APDs with relatively high structural similarity. Theoretically, a
single reaction would be sufficient to connect both intermediates
to a substrate-product pair and thus to complete the entire
biosynthetic pathway (Figure 6A). This reaction represents the
already predicted cleavage of the oxalyl residue. However, this
cleavage will not occur from previously proposed intermediate 3
but rather from 16 (for 3C APD).
The only remaining putative PPL biosynthetic protein with
an unassigned function is LmbA (assuming no dual function
of any of the preceding or following proteins LmbB2, B1,
W, X, and Y). Bioinformatics analysis of LmbA does not
indicate any apparent relevant C–C cleavage activity for a
similar transformation because it belongs to the family of
γ-glutamyltransferases (Castellano and Merlino, 2012). However,
the sequence homology corresponds neither to the previously
proposed function of the LmbA protein, i.e., attachment of the
glutamyl residue in the biosynthesis of F420 cofactor, which is
required for F420-dependent reductase LmbY (Peschke et al.,
1995; Li et al., 2009b). This reaction is generally catalyzed
by coenzyme F420:L-glutamate ligase (Li et al., 2003), which
does not exhibit any homology to γ-glutamyltransferases. The
participation of the LmbY and LmbA proteins in the same
biosynthetic step is also unambiguously disproved by the
distinct production profiles of the 1lmbY and 1lmbA strains
(Figure 3). Considering all these facts, we should contemplate the
possibility that LmbA could cleave 16 through some yet unknown
mechanism.
Here, we propose a hypothetical mechanism that can solve this
rebus using only the expected γ-glutamyltransferase activity of
LmbA (Figure 6B). According to our hypothesis, the cleavage of
16 will be initiated by glutamate transfer to the imine nitrogen
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FIGURE 7 | Functions of LmbX and LmbY. (A) Proposed mechanism of LmbX and LmbY functions (wt strain); square brackets indicate unstable intermediates of
reactions. (B) Proposed pathway leading to DH-LIN A1 (13a) and DH-LIN A3 (13b) in 1lmbX; (C) Proposed pathway leading to DH-LIN A2 (14a) in 1lmbY.
? – structure of DH-LIN A4 (14b) is unknown; however, it could be the second stereoisomer of 14a (at double bond of amino acid moiety); ∗ – presence of this
compound is expected only, because 7 is not distinguished in LC–MS chromatograms.
of 16, leading to a positively charged nitrogen atom. This should
lead to destabilization of intermediate I, resulting in an extensive
shift of double bonds across a large part of the molecule,
ultimately leading to the cleavage of oxalate. Subsequently, the
glutamyl residue from intermediate II is removed, presumably by
LmbA, to afford 9.
OXO-LIN A, an oxygen-containing derivative of lincomycin,
which is produced as the main product by the 1lmbA
strain as well as in trace amounts by several other strains
(Figure 3A), is likely formed by the spontaneous decarboxylation
of intermediate 3 (we observed significant decarboxylation of 3
in the presence of metal ions – data not shown), followed by
reduction of double bonds (for details of the proposed pathway
see Supplementary Figure S3). The low or only trace amount
of OXO-LIN A production also confirms that this mechanism
represents only a shunt pathway, which is not competitive with
the natural biosynthesis.
MATERIALS AND METHODS
Bacterial Strains and Chemicals
The type strain S. lincolnensis ATCC 25466 producing lincomycin
was used for the preparation of all mutant strains. Routine
DNA manipulations were performed in Escherichia coli JM109
(Promega). The heterologous expression of S. lincolnensis genes
was performed in E. coli BL21(DE3; Novagen). E. coli ET12567,
BW25113, GM2929, and DH5α strains were used for gene
inactivation.
Lincomycin A (containing lincomycin B as an impurity) was
purchased from Sigma-Aldrich (Germany), and the standards of
PPL, EPL and L-4-(2-oxo-3-butenoic-acid)-4,5-dihydropyrrole-
2-carboxylic acid (3) were prepared as described in the literature
(Novotna et al., 2004; Kamenik et al., 2009). Acetonitrile and
methanol (both LC–MS grade) were obtained from Biosolve BV
(Netherlands), formic acid (98–100%; Merck KGaA, Germany),
and ammonium hydroxide (28–30% A. C. S. reagent; Sigma-
Aldrich, Germany).
Gene Inactivation
Selected genes encoding proteins involved in the PPL pathway
were inactivated by the introduction of apramycin resistance
cassette pIJ773 using the REDIRECT technology kit (Plant
Bioscience Limited, Norwich Research Park, UK) for PCR
targeting (Gust et al., 2004). The inactivation and checking
primers are listed in Supplementary Table S2. To construct
1lmbA, 1lmbW, 1lmbX and 1lmbY mutants, the inactivation
cassette was replaced by an 81-nt-long in-frame scar. Double
mutant 1lmbW1lmbX was prepared by the introduction of a
hygromycin resistance cassette from pIJ798 instead of lmbW
and the apramycin resistance cassette from pIJ773 instead of
lmbX.
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Cultivation of S. lincolnensis Strains
The seed culture of S. lincolnensis strains was prepared by
inoculation from MS plates into 40 ml of YEME medium (Kieser
et al., 2000) without sucrose and incubated in 500 ml flat-bottom
boiling flasks at 28◦C. Two milliliters of 24 h seed culture of
S. lincolnensis were transferred into 40 ml of AVM medium
(Najmanova et al., 2014) and incubated in 500 ml flat-bottom
boiling flasks at 28◦C for 120 h. The cells were centrifuged at
5000 g at 4◦C for 15 min, and the supernatant was used for
solid-phase extraction.
Complementation of S. lincolnensis
1lmbA and 1lmbX
The lmbA and lmbX genes were PCR amplified from the
LK6 cosmid (Koberska et al., 2008) using the primer
pairs fA10257N/rA10257N and ExXf /ExXr, respectively
(Supplementary Table S2). The appropriate amplified sequence
was inserted via the NdeI and XhoI restriction sites into an
integrative vector pIJ10257 (Hong et al., 2005). The resulting
construct was introduced into non-methylating strain E. coli
ET12567/pUZ8002 and then introduced into the genome of
S. lincolnensis 1lmbA (for the construct containing lmbA) or
1lmbX (for the construct containing lmbX) via intergeneric
conjugal transfer. Exconjugants were selected with hygromycin
(0.1 g/l).
Heterologous Production of LmbX and
LmbW Proteins in E. coli
Genes lmbX and lmbW were PCR amplified from LK6 cosmid
using primer pairs ExX and ExW (Supplementary Table S2). The
products were inserted into pET28b(+; lmbX) or pET42b(+;
lmbW) vector (Novagen). The resulting constructs were used to
produce soluble proteins in E. coli BL21(DE3; Novagen); LmbX
required co-expression with GroES and GroEL chaperonins.
The proteins were produced and purified as was described for
LmbC (Kadlcik et al., 2013) with the following modifications.
The post-induction production of LmbX was conducted at
17◦C for 20 h; LmbX required 20% glycerol in all buffers. The
protein was dialyzed overnight against TS-8 buffer (Kadlcik et al.,
2013) containing 20% glycerol and immediately used. The post-
induction production of LmbW was performed at 28◦C for 4 h.
The protein was dialyzed against 40 mM glycine buffer pH 9.5
and immediately used.
In Vitro and In Vivo Assays with LmbX
The enzymatic activity of LmbX was tested with 3 as a substrate
in the following reaction mixtures: LmbX (1 mg/ml), 3 (10 mM)
and 20% glycerol in a buffer. Several buffers were tested: 20 mM
Tris-HCl pH 7, 8, and 9 with and without 100 mM NaCl and
100 mM phosphate buffer pH 7, 8, and 9 with and without
100 mM NaCl. Moreover, the addition of various metal ions was
tested: Ca2+, Cu2+, Fe3+, Mg2+, Mn2+, and Zn2+ (10 mM).
The reactions with a total volume of 100 µl were incubated
at 28◦C for 1 h, terminated with 1 µl of formic acid and
subsequently analyzed using LC–MS. An in vivo experiment was
also conducted. Compound 3 (5 mM) was added to bacterial
culture BL21(DE3; 6 ml) expressing the lmbX gene under the
same conditions that were used for the heterologous production
of LmbX. The culture medium and supernatant from sonicated
cells were analyzed using LC–MS.
In Vitro Assays with LmbW
The enzymatic activity of LmbW with 3 as a substrate was tested
in reaction mixtures containing LmbW (1 mg/ml), 3 (4 mM), and
S-adenosylmethionine (4 mM) in glycine buffer (40 mM, pH 9.5).
The reactions with a total volume of 100 µl were incubated at
28◦C for 1 h, terminated with 1 µl of formic acid and analyzed
using LC–MS.
Extraction of Amino Acid Precursors
Oasis MCX 3cc 60 mg cartridge (mixed-mode cation exchange
sorbent, Waters, USA) was conditioned with 3 ml methanol,
equilibrated with 3 ml 2% formic acid and then 3 ml
cultivation broth (pH adjusted to 2.3 with formic acid) was
loaded. Subsequently, the cartridge was washed with 3 ml
water and absorbed substances were eluted with 1.5 ml
methanol:water:ammonium hydroxide solution (50:48.5:1.5
v/v/v). The eluent was evaporated to dryness, reconstituted in
300 µl methanol:water (1:1 v/v) and centrifuged at 13000 rpm
for 5 min. Two µl of the extract were injected into LC–MS.
Extraction of Lincomycin Derivatives
Oasis HLB 3cc 60 mg cartridge (hydrophilic-lipophilic balanced
sorbent, Waters, USA) was conditioned with 3 ml methanol,
equilibrated with 3 ml water and then 3 ml cultivation broth
(pH adjusted to 9.0 with ammonium hydroxide) was loaded.
Subsequently, the cartridge was washed with 3 ml water and
absorbed substances were eluted with 1.5 ml methanol. The
eluent was evaporated to dryness, reconstituted in 150 µl
methanol and centrifuged at 13000 rpm for 5 min. The extract
was then diluted 10×with methanol:water (1:1 v/v) and 2 µl were
injected into LC–MS.
LC–MS Analyses
The samples were analyzed on an Acquity UPLC system with
an LCT premier XE time-of-flight mass spectrometer (Waters,
USA) using the LC Column Acquity UPLC BEH C18 kept at
the temperature of 30◦C (50 mm × 2.1 mm I.D., particle size
1.7 µm, Waters, USA) and a two-component mobile phase at the
flow rate of 0.4 ml/min. The mass spectrometer was operated in
the “W” mode with the capillary voltage set at +2800 (positive
ionization mode) or −2500 V (negative ionization mode), cone
voltage of +40 or −40 V, desolvation gas temperature of 350◦C,
ion source block temperature of 120◦C, cone gas flow of 50 l/h,
desolvation gas flow of 800 l/h, scan time of 0.1 s, and inter-scan
delay of 0.01 s. Fragmentation by collision-induced dissociation
(CID) was triggered by setting the aperture 1 value at 50 V.
Lincomycin quantification was performed using a standard of
lincomycin A spiked into the analyte-free cultivation broth at the
required concentration. The data were processed using MassLynx
V4.1, and the quantification was performed using the QuanLynx
application manager (Waters). Tentative identification of the
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structures was based on the elemental composition determined
from accurate mass and isotopic patterns and, for some of the
structures, on in-source CID MS fragmentation and comparison
of retention times with those of available authentic standards.
Chromatographic Conditions
(1) For analysis of amino acid precursors: the two component
mobile phase, A and B, consisted of 0.1% formic acid and
methanol, respectively. The analyses were performed under a
linear gradient program (min/%B) 0/5, 5/5, 10/20, 15/50 followed
by a 1.5 min column clean-up (99% B) and a 1.5 min equilibration
(5% B). The total analysis time was 18 min.
(2) For analysis of lincomycin derivatives: the two component
mobile phase, A and B, consisted of 1 mM ammonium
formate pH 9.0 and acetonitrile, respectively. The analyses were
performed under a linear gradient program (min/%B) 0/5,
1.5/5.0, 10.0/30, followed by a 2 min column clean-up (80% B)
and a 2 min equilibration (5% B). The total analysis time was
14 min.
(3) For analysis of reaction mixtures: the reaction mixtures
were centrifuged at 13000 rpm for 5 min and analyzed as
described above for the analysis of amino acid precursors except
for the linear gradient program, which was (min/%B) 0/5.0,
1.5/5.0, 5.5/9.4 followed by a 1 min column clean-up (100% B)
and a 1.5 min equilibration (5% B).
Lincomycin A Quantification
Lincomycin quantification was performed under the same
chromatographic conditions as described above for the analysis
of lincomycin derivatives. The extract reconstituted in 150 µl
methanol was 2× diluted with water and injected into LC. The
column eﬄuent was monitored by UV detection at 194 nm. The
calibration curve was prepared using a standard of lincomycin
A spiked into the analyte-free extract of cultivation broth. The
six calibration points in the range 6.25–200 µg/ml were fitted
linearly with the determination coefficient of 0.9997. Lincomycin
A production was determined for wt and 1lmbY strains in
three independent cultures. The method was developed by
a modification of a validated method for determination of
lincomycin A (Olsovska et al., 2007).
Purification of Lincomycin Derivatives
Cultivation broth was loaded onto 10 g of Amberlite XAD-4
sorbent (Supelco, USA) pre-conditioned with 100 ml methanol
and 100 ml water. The sorbent was washed with 100 ml
water and the absorbed compounds were gradually eluted with
methanol:water of increasing ratio of methanol (from 20%
methanol to 100% methanol, 10% steps, 50 ml fractions).
Fractions containing lincomycin derivatives were evaporated to
dryness, reconstituted in methanol and injected into the HPLC
apparatus equipped with flow controller 600, autosampler 717,
and UV detector 2487 operating at 194 nm (Waters, USA).
Data were processed with Empower 2 software (Waters, USA).
The samples were separated on the Luna C18 chromatographic
column (250 mm× 15 mm I.D., particle size 5 µm, Phenomenex,
USA) with the two component mobile phase, A and B, consisted
of 0.1% formic acid and methanol, respectively. The analyses
were performed under a linear gradient program (min/%B) 0/5,
31/27.5 followed by a 9 min column clean-up (100% B) and
a 9 min equilibration (5% B), at the flow rate of 3 ml/min.
The fractions containing lincomycin derivatives were evaporated
to dryness, reconstituted in methanol and injected onto the
XTerra Prep RP18 column (150 mm × 7.8 mm I.D., particle size
5.0 µm, Waters, USA). The lincomycin derivatives were eluted
using the isocratic program with 1 mM ammonium formate
(pH 9.0):acetonitrile (83:17 v/v) as mobile phase. The fractions
containing the separated lincomycin derivatives were checked for
purity (at least 95%, LC with UV detection at 220 nm) and used
for NMR analysis.
NMR Analysis
NMR spectra were recorded on a Bruker Avance III 700 MHz
spectrometer (700.13 MHz for 1H, 176.05 MHz for 13C) in
CD3OD (99.8 atom% D, VWR Chemicals, Leuven, Belgium)
at 20◦C. Residual signals of solvent were used as an internal
standard (δH 3.330, δC 49.30). 1H NMR, 13C NMR, COSY, HSQC,
HMBC, and 1D TOCSY experiments were performed using the
manufacturer’s software. 1H NMR and 13C NMR spectra were
zero filled to fourfold data points and multiplied by a window
function prior to Fourier transformation. A two-parameter
double-exponential Lorentz-Gauss function was applied for 1H
to improve the resolution, and line broadening (1 Hz) was
applied to obtain a better 13C signal-to-noise ratio. Chemical
shifts are given in δ-scale with digital resolution justifying the
reported values to three (δH) or two (δC) decimal places. Coupling
constants (J) are in Hz. Some chemical shifts were read out from
HSQC spectra. They are given to two (δH) or one (δC) decimal
places.
Bioinformatics Tools
Sequences homologous to proteins LmbA, LmbW, LmbX, and
LmbY were searched using blastp (http://blast.ncbi.nlm.nih.gov/
Blast.cgi; (Altschul et al., 1997)).
CONCLUSION
The newly proposed pathway for the biosynthesis of PPL
does not have the ambition to bring all desired answers and
proofs. We realize that the ultimate confirmations represent a
challenging and long-term task due to a limited availability of
the relevant substrates as well as the solubility problems with
recombinant proteins (LmbA, LmbY). However, the scheme has
been proposed with the hope that it can unblock the situation
where several decades accepted scheme, clearly contradictory to
our current knowledge, struggles to resolve the individual steps
of the biosynthesis.
Our scheme is applicable not only for the biosynthesis
of PPL (or 2C APD precursor EPL) but also to a large
extent for other APD precursors that are biosynthesized
through homologous pathways (only a difference in the
final reduction step is presumed). Our study thus provides
insights into the biosynthetic machinery of three structurally
and functionally distinct groups of bioactive compounds:
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lincosamides, pyrrolobenzodiazepines, and hormaomycin.
Because of their bioactivity, all of these compounds are
intriguing from the perspective of the pharmaceutical industry.
In particular, the antibiotic lincomycin, binding to ribosomes,
and the anticancer pyrrolobenzodiazepines, binding to DNA,
have been extensively studied from this perspective. Importantly,
it has been shown that specific modification of the APD moiety
has a significant effect on the bioactivity. Therefore, probing the
biosynthetic machinery of these moieties is an important step for
the preparation of improved derivatives of these compounds.
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